Product Images Ranolazine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Ranolazine NDC 45963-418 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
1 - image 1
1 - image 2
1 - image 3
1 - image 4
1 - image 5
1 - image 6
The text describes the medication "Ranolazine", which is present in extended-release tablets containing 500mg of the compound. The tablets should be swallowed whole and not be crushed, broken or chewed. The dosage should be followed as per accompanying literature. The medication should be stored at controlled room temperature and dispensed in a light-resistant container. The medication should be kept out of the reach of children. This medication is manufactured by Teva Pharmaceuticals USA, Inc. The NDC code for this medication is 45963-418-06.*
1 - image 7
This text describes the dosage and administration instructions for Ranolazine extended-release tablets along with its ingredients and storage instructions. The tablet should be swallowed whole and should not be crushed or chewed. Each tablet contains 1,000 mg of Ranolazine, and the usual dosage should be followed as suggested in the accompanying literature. The tablets should be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication should be kept in a tight, light-resistant container and away from children. The code 45963-419-06 refers to the identification number of the product.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.